Health: Public Affairs & Public Relations Support
Brevia Health provides straightforward public affairs and communications advice and support to organisations operating in the highly regulated UK healthcare sector. The consultancy brings together experts who have held senior roles in NICE, MHRA, Government Health teams, Opposition Health teams and across industry. We use this rounded perspective to bring new thinking and well-developed proposals across a wide range of policy areas.
As the UK emerges from the far-reaching consequences of COVID-19 and BREXIT, it is clear that the healthcare system has changed, and leaders are open to new approaches. Never has there been a better time for organisations to make practical, thought-through proposals which show broad-based benefits.
The much anticipated publication of the NHS Commercial Framework for New Medicines in 2021 represents a significant milestone for the pharmaceutical industry. It outlines the purpose and principles on which NHS commercial medicines activity will be based, defines the roles and responsibilities of those involved in commercial medicines activity and details how pharmaceutical companies can engage with the NHS.
Brevia Health supports global multi-nationals, innovative start-ups, providers, and charities. Our experience includes supporting companies to win IT contracts with the NHS through to gaining approval for medicines with NICE. We have also worked in areas such as in vitro diagnostics, medical devices, and genomics, as well as delivering programmes involving policy and stakeholder research, political and media monitoring, stakeholder engagement, event management, media relations, Party Conferences, and Select Committee training.
For more information about Brevia Health, our client experience and team of health consultants, please visit our dedicated website: www.breviahealth.com.
To organise a discussion with Brevia Health on how we can help you and your organisation, please get in touch via the link here. You can also contact the Brevia Health Team on 020 7091 1655 or email contact@breviahealth.com
OUR SENIOR COUNSEL INCLUDES:
CLIENT EXPERIENCE
TESTIMONIALS
NEWS
RIS3 Explained: National Highways’ £8.4bn Renewals Programme Under Scrutiny
The ORR’s latest assessment flags delivery risk in National Highways’ £8.4bn RIS3 renewals programme. Here’s what it means for RP3 and beyond.
How to Submit a Representation to HM Treasury for Autumn Budget 2026
HM Treasury has opened its portal for Autumn Budget 2026 representations. Read Brevia’s breakdown of key dates, Treasury evaluation criteria, and strategic public affairs advice to ensure your submission delivers maximum impact.
Miatta Fahnbulleh: What does the new DESNZ Secretary of State mean for UK energy policy?
The appointment of Miatta Fahnbulleh MP as Secretary of State for Energy Security and Net Zero was one of the most intriguing appointments made by the new Prime Minister Andy Burnham MP. Having previously served as Minister for Energy Consumers, Fahnbulleh returns to the Department she initially joined as a junior minister immediately in 2024, but this time at its helm. In this article, Brevia reviews Fahnbulleh’s expected direction, what her appointment signals for energy policy and the issues businesses should be watching over the coming months.
WORK WITH US
A track record in delivering results
Brevia Health delivers tailored support to businesses and charities operating in the health sector. Our three-step process offers a straightforward approach to delivering crucial intelligence, strategic advice and stakeholder engagement.